A61K 38/05
Dipeptides
A61K38/05 (Dipeptides) appears on 1,195 US grants and 2,036 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,195
- Published applications
- 2,036
- Assignees
- 935
- Inventors
- 3,693
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 3 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 2 | 0 |
| 1991 | 5 | 0 |
| 1992 | 7 | 0 |
| 1993 | 2 | 0 |
| 1994 | 4 | 0 |
| 1995 | 4 | 0 |
| 1996 | 7 | 0 |
| 1997 | 13 | 0 |
| 1998 | 19 | 0 |
| 1999 | 26 | 0 |
| 2000 | 24 | 0 |
| 2001 | 25 | 9 |
| 2002 | 24 | 38 |
| 2003 | 21 | 32 |
| 2004 | 19 | 53 |
| 2005 | 19 | 51 |
| 2006 | 17 | 61 |
| 2007 | 20 | 52 |
| 2008 | 15 | 32 |
| 2009 | 15 | 60 |
| 2010 | 22 | 57 |
| 2011 | 23 | 64 |
| 2012 | 30 | 45 |
| 2013 | 38 | 77 |
| 2014 | 54 | 113 |
| 2015 | 69 | 129 |
| 2016 | 72 | 151 |
| 2017 | 65 | 166 |
| 2018 | 81 | 128 |
| 2019 | 91 | 111 |
| 2020 | 76 | 109 |
| 2021 | 74 | 96 |
| 2022 | 51 | 92 |
| 2023 | 41 | 93 |
| 2024 | 45 | 91 |
| 2025 | 44 | 68 |
| 2026 | 24 | 58 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Extract of bacteria of the genus Sphingomonas29 Sep 2026US 12,746,260 B2L'oreal
- Small molecule LIN28 inhibitors as anticancer agents22 Sep 2026US 12,741,987 B2Arumugavadivel Narendran
- Small molecule inhibitors of SARS-CoV-2 viral replication and uses thereof25 Aug 2026US 12,715,896 B2Arizona Board of Regents on Behalf of the University of Arizona
- Methods for treating metastasis with cathepsin C inhibitors4 Aug 2026US 12,697,328 B2Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences
- Thermogenic compositions and methods4 Aug 2026US 12,697,366 B2Ohio State Innovation Foundation
- Methods of enhancing antibody therapies8 Oct 2026US 2026/0308270 A1Ohio State Innovation Foundation
- Cleavable radioligands for targeting cell surface receptors and uses thereof1 Oct 2026US 2026/0295099 A1Full-Life Technologies UK Limited
- Methods for the treatment of t-cell acute lymphoblastic leukemia24 Sep 2026US 2026/0284190 A1Centre National De La Recherche Scientifique
- Methods for predicting responsiveness to daratumumab in a cancer subject24 Sep 2026US 2026/0286445 A1Allarity Therapeutics, Inc.
- Stable liquid bortezomib formulations17 Sep 2026US 2026/0273016 A1Riconpharma LLC
Most cited
By later US patents
- Prolonged release microcapsule and its production372US 4,652,441 ATakeda Chemical Industries, Ltd. · 1987
- Prolonged release microcapsule of a water-soluble drug226US 5,061,492 ATakeda Chemical Industries, Ltd. · 1991
- Prolonged release microcapsules and their production146US 4,711,782 ATakeda Chemical Industries, Ltd. · 1987
- Solubilization of pharmaceutical substances in an organic solvent and preparation of pharmaceutical powders using the same125US 5,981,474 AUniversity Technology Corporation · 1999
- Solubilization of pharmaceutical substances in an organic solvent and preparation of pharmaceutical powders using the same121US 5,770,559 AThe Regents of the University of Colorado · 1998